Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome

Nibras Abbas AL-Mansouri, Hind S. ALhamdani, Haider A. Mahdi

Research Article | Open Access | Download Full Text

Volume 1 | Issue 2 | Year 2025 | Article Id: RLS-V1I2P101

Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome

Nibras Abbas AL-Mansouri, Hind S. ALhamdani, Haider A. Mahdi

Received	Revised	Accepted	Published
18 Jul 2025	20 Aug 2025	05 Sep 2025	16 Sep 2025

Citation

Nibras Abbas AL-Mansouri, Hind S. ALhamdani, Haider A. Mahdi. “Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome.” DS Reviews of Research in Life Sciences, vol. 1, no. 2, pp. 1-8, 2025.

Abstract

The most common endocrine condition that affects fertile women worldwide is known as polycystic ovarian syndrome, or PCOS. Depending on the diagnostic criteria applied, the prevalence might range from 5% to 15%. The presence of two of the three criteria—polycystic ovaries, clinical or biological hyperandrogenism, and chronic anovulation—must be present for PCOS to be diagnosed under the recommendations of specialized societies. DHEA and DHEA-S levels of androgens are frequently high in women with PCOS. Acne, irregular menstruation periods, and hirsutism excessive hair growth can all be indications of this hormonal imbalance. Two groups were involved in the study: one hundred women in the patient group, which is the initial group. Between October 1, 2023, and March 1, 2024, 50 patients and 50 healthy individuals served as controls, as determined by a team of experienced gynecologists at the Fertility Center in AL-Sadder Medical City in Najaf Province, Iraq. 5 ml of blood were drawn from a brachial vein using sterile medical syringes on female subjects who were in the luteal phase for this investigation. The blood was then put in a gel. To determine LH, FSH, Prolactin, DHEA, TNF-α, and IL-6 using an ELISA kit (Elabscience, USA) and lipid profile using an automated biochemistry analyzer (Beckman Coulter, USA), the serum was extracted, put in Eppendorf tubes, and deep frozen at -20 °C. According to the current study’s findings, POCS women’s levels of DHEA are much higher than those of healthy women. Additionally, the research demonstrated that, when compared to healthy controls, women with polycystic syndrome had significantly higher blood levels of IL6 and TNF-α. The results clearly show a correlation between PCOS and increased DHEA, IL-6, and TNF-α levels.

Keywords

Polycystic ovary syndrome, DHEA, TNF-α.

References

[1] Merve Esra Çıtar Dazıroğlu, and Nilüfer Acar Tek, “The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome,” Current Nutrition Reports, vol. 12, no. 1, pp. 191-202, 2023.

[CrossRef] [Google Scholar] [Publisher Link]

[2] Miguel A. Sanchez-Garrido, and Manuel Tena-Sempere “Metabolic Dysfunction in Polycystic Ovary Syndrome: Pathogenic Role of Androgen Excess and Potential Therapeutic Strategies,”Molecular Metabolism, vol. 35, 2020.

[CrossRef] [Google Scholar] [Publisher Link]

[3] Betcy Susan Johnson, and Malini Laloraya, “Polycystic Ovary Syndrome and Immune Deregulation: What do Hormones Want to Say?” Exploration of Immunology, vol. 2, no. 3, pp. 393-413, 2022.

[CrossRef] [Google Scholar] [Publisher Link]

[4] Carmina, Enrico, and Rosa Alba Longo, “Increased Prevalence of Elevated Dheas in Pcos Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 To 29 Years,” Cells, vol. 11, no. 20, 2022.

[CrossRef] [Google Scholar] [Publisher Link]

[5] Sanjana Kumariya et al., “Autophagy in Ovary and Polycystic Ovary Syndrome: Role, Dispute and Future Perspective,” Autophagy, vol. 17, no. 10, pp. 2706-2733, 2021.

[CrossRef] [Google Scholar] [Publisher Link]

[6] Xinghua Xu et al., “Effect of Metformin on Serum Interleukin-6 Levels in Polycystic Ovary Syndrome: A Systematic Review,” BMC Women’s Health, Vol. 14, pp. 1-7, 2014.

[CrossRef] [Google Scholar] [Publisher Link]

[7] Yue Zhang et al. “The Association between a Body Shape Index and Elevated Urinary Albumin–Creatinine Ratio in Chinese Community Adults,” Frontiers in Endocrinology, Vol. 13, 2022.

[CrossRef] [Google Scholar] [Publisher Link]

[8] Atheer A. Mehde, and Ali K. Resan, “Study of Several Biochemical Features in Sera of Patients with Polycystic Ovaries and Compared with the Control Group,” Australian Journal of Basic and Applied Sciences, vol. 8, no. 10, pp. 620-627, 2014.

[Google Scholar] [Publisher Link]

[9] Sherif F. ELMekkawi et al., “Effect of Metformin Therapy on Serum Interleukin-6 and Interleukin-18 Levels in Patients with Polycystic Ovary Syndrome,” New York Science Journal, vol. 3, pp. 83-86, 2010.

[Google Scholar]

[10] Ateia Yaser Abbas et al., “Levels of Some Proinflammatory Cytokines in Obese Women with Polycystic Ovary Syndrome after Metformin Therapy.” Al-Kindy College Medical Journal, vol. 9, no. 2, pp. 45-48, 2013.

[Google Scholar] [Publisher Link]

[11] Elif Agacayak et al., “Levels of Neopterin and Other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome,” Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, vol. 21, pp. 2446-2455, 2015.

[CrossRef] [Google Scholar] [Publisher Link]

[12] Sana Siddiqui et al., “A Brief Insight into the Etiology, Genetics, and Immunology of Polycystic Ovarian Syndrome (PCOS),” Journal of Assisted Reproduction and Genetics, vol. 39, no. 11, pp. 2439-2473, 2022.

[CrossRef] [Google Scholar] [Publisher Link]

[13] Qingfen Chen et al., “Explore the Potential Molecular Mechanism of Polycystic Ovarian Syndrome by Protein–Protein Interaction Network Analysis,” Taiwanese Journal of Obstetrics and Gynecology, vol. 60, no. 5, pp. 807-815, 2021.

[CrossRef] [Google Scholar] [Publisher Link]

[14] Chun Yuan et al., “Polycystic Ovary Syndrome Patients with High BMI Tend to have Functional Disorders of Androgen Excess: A Prospective Study,” The Journal of Biomedical Research, vol. 30, no. 3, 2016.

[CrossRef] [Google Scholar] [Publisher Link]

[15] Ai Sita Nurain et al., “The Relationship between Obesity and Level of Polycystic Ovary Syndrome (PCOS): Literature Review,” Proceedings of the International Conference on Health and Well-Being (ICHWB 2021), Atlantis Press, pp. 218-226, 2022.

[CrossRef] [Google Scholar] [Publisher Link]

[16] Homeira Rashidi et al., “To What Extent does the use of the Rotterdam Criteria Affect the Prevalence of Polycystic Ovary Syndrome? A community-Based Study from the Southwest of Iran.” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 174, pp. 100-105, 2014.

[CrossRef] [Google Scholar] [Publisher Link]

[17] Jin Ju Kim et al.,” Complete Phenotypic and Metabolic Profiles of a Large Consecutive Cohort of Untreated Korean Women with Polycystic Ovary Syndrome,” Fertility and Sterility, vol. 101, no. 5, pp. 1424-1430, 2014.

[CrossRef] [Google Scholar] [Publisher Link]

[18] Julie Tomlinson et al., “The Diagnosis and Lived Experience of Polycystic Ovary Syndrome: A Qualitative Study,” Journal of Advanced Nursing, vol. 73, no. 10, pp. 2318-2326, 2017.

[CrossRef] [Google Scholar] [Publisher Link]

[19] Tharwat Ahmed El-Sayed Ibrahim, Ali El-Sharbrawy Ali, and Mohamed El-Husseiny Radwan, “Lipid Profile in Women with Polycystic Ovary Syndrome,” The Egyptian Journal of Hospital Medicine, vol. 78, no. 2, pp. 272-277, 2020.

[CrossRef] [Google Scholar] [Publisher Link]

[20] Anuja Dokras et al.,”Androgen Excess-Polycystic Ovary Syndrome Society: Position Statement on Depression, Anxiety, Quality of Life, and Eating Disorders in Polycystic Ovary Syndrome,” Fertility and Sterility, vol. 109, no. 5, pp. 888-899, 2018.

[CrossRef] [Google Scholar] [Publisher Link]

[21] Zaheera Saadia,”Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS)-Obese vs. Non-Obese Women,” Medical Archives, vol. 74, no. 4, pp. 289-293, 2020.

[CrossRef] [Google Scholar] [Publisher Link]

[22] Saif M. Hassan et al., “The Potential Antiviral Activity of a Novel Pyrimidine Derivative against Herpes Simplex Virus Type-1 (HSV-1),” Systematic Reviews in Pharmacy, vol. 11, no. 2, pp. 795-806, 2020.

[Google Scholar] [Publisher Link]

[23] Fatema Ali AL kafhage et al., “The Relationship between Hormonal Levels and Hematological Parameters in Cystic Ovarian Syndrome,” Journal of Medicine and Life, vol. 16, no. 6, pp. 937-940, 2023.

[CrossRef] [Google Scholar] [Publisher Link]

[24] Zahra Davoudi et al., “Prolactin Level in Polycystic Ovary Syndrome (PCOS): An Approach to the Diagnosis and Management,” Acta Biomedica, vol. 92, no. 5, pp. 1-7, 2021.

[CrossRef] [Google Scholar] [Publisher Link]

[25] Elisabeth Lerchbaum et al., “Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype,” PLOS one, vol. 9, no. 10, pp. 1-12, 2014.

[CrossRef] [Google Scholar] [Publisher Link]

[26] Maryam Rostamtabar et al., “Pathophysiological Roles of Chronic Low‐Grade Inflammation Mediators in Polycystic Ovary Syndrome,” Journal of Cellular Physiology, vol. 236, no. 2, pp. 824-838, 2021.

[CrossRef] [Google Scholar] [Publisher Link]

[27] Shaimaa Aboeldalyl et al., “The Role of Chronic Inflammation in Polycystic Ovarian Syndrome—A Systematic Review and Meta-Analysis,” International Journal of Molecular Sciences, vol. 22, no. 5, 2021.

[CrossRef] [Google Scholar] [Publisher Link]

[28] María L Sánchez-Ferrer et al., “Are there Differences in Basal Thrombophilias and C-Reactive Protein Between Women with or without PCOS?,” Reproductive Biomedicine Online, vol. 38, no. 6, pp. 1018-1026, 2019.

[CrossRef] [Google Scholar] [Publisher Link]

[29] Mohd Ashraf Ganie et al., “Comparative Evaluation of Biomarkers of Inflammation among Indian Women with Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-Vegetarian Diet,” Frontiers in Endocrinology, vol. 10, 2019.

[CrossRef] [Google Scholar] [Publisher Link]

[30] Robert L. Rosenfield, and David A. Ehrmann, “The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited,” Endocrine Reviews, vol. 37, no. 5, pp. 467–520, 2016.

[CrossRef] [Google Scholar] [Publisher Link]

[31] Lingling Gao, Yang Gu, and Xianghua Yin, “High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis,” PLOS One, vol. 11, no. 10, pp. 1-18, 2016.

[CrossRef] [Google Scholar] [Publisher Link]

[32] Ricarda Haustein et al., “C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation,” Cells, vol. 12, no. 3, pp. 443-460, 2023.

[CrossRef] [Google Scholar] [Publisher Link]

[33] Zahraa Isam Jameel, “MicroRNA Biogenesis, Mechanisms of Function, Circulation and Application Role in Human Diseases,” International Journal of Scientific Research in Biological Sciences, vol. 10, no. 5, pp. 71-80, 2023.

[Google Scholar] [Publisher Link]

[34] Zahraa Isam Jameel, “Bioinformatics Usage, Application and Challenges to Detect Human Genetic Diseases (Mini Review),” International Journal of Scientific Research in Biological Sciences, vol. 10, no. 5, pp. 59-67, 2023.

[Google Scholar] [Publisher Link]